TickerLeague

Buyback Spend for AbbVie (ABBV)

Buyback Spend for AbbVie (ABBV): headline value $980.00M · YoY -42.6%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

AbbVie Inc. logo
AbbVie

ABBV

Latest period

$980.00M

YoY change

-42.6%

5Y CAGR

+0.0%

Peak year (2018)

$12.01B

Latest annual

$980.00M

Buyback Spend history chart for AbbVie (ABBV) from 2009 to 2025

Buyback Spend history table for AbbVie (ABBV) from 2009 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$980.00M-42.6%
2024$1.71B-13.4%
2023$1.97B+32.6%
2022$1.49B+59.2%
2021$934.00M-4.5%
2020$978.00M+55.5%
2019$629.00M-94.8%
2018$12.01B+752.1%
2017$1.41B-76.6%
2016$6.03B-20.5%
2015$7.59B+1040.8%
2014$665.00M+107.8%
2013$320.00M
2012$0
2011$0
2010$0
2009$0

Buyback Spend values are taken from AbbVie's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, AbbVie (ABBV) buyback spend totalled $980.00M – plunged 42.6% year-over-year.

AbbVie buyback spend has recorded the values shown across consecutive periods, with a +0.0% compound annual growth rate over 2020–2025 (5 years).

Between 2018 and 2025, AbbVie buyback spend plunged 91.8%, falling from $12.01B to $980.00M.

$12.01B stands as the all-time-high annual buyback spend, posted in 2018, against a low of $0 during 2009.

Among 8 Healthcare peers, AbbVie (ABBV) ranks 7th; the peer median for buyback spend is $3.55B.

AbbVie Buyback Spend by Year

AbbVie Buyback Spend 2025: $980.00M

AbbVie buyback spend in 2025 was $980.00M, plunged 42.6% below 2024.

AbbVie Buyback Spend 2024: $1.71B

AbbVie buyback spend in 2024 was $1.71B, declined 13.4% below 2023.

AbbVie Buyback Spend 2023: $1.97B

AbbVie buyback spend in 2023 was $1.97B, surged 32.6% from 2022.

AbbVie Buyback Spend 2022: $1.49B

AbbVie buyback spend in 2022 was $1.49B, surged 59.2% from 2021.

AbbVie Buyback Spend 2021: $934.00M

AbbVie buyback spend in 2021 was $934.00M.

See more financial history for AbbVie (ABBV).

Sector peers — Buyback Spend

Companies in the same sector as AbbVie, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Thermo Fisher Scientific Inc. (TMO)$3.00BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is AbbVie's buyback spend?

Latest reported buyback spend for AbbVie (ABBV) is $980.00M (period ending December 31, 2025).

How has AbbVie buyback spend changed year-over-year?

AbbVie (ABBV) buyback spend changed -42.6% year-over-year on the latest annual filing.

What is the long-term growth rate of AbbVie buyback spend?

AbbVie (ABBV) buyback spend compound annual growth rate is +0.0% over the most recent 5 years available.

When did AbbVie buyback spend hit its highest annual value?

AbbVie buyback spend reached its highest annual value of $12.01B in 2018.

What was AbbVie buyback spend in 2024?

AbbVie (ABBV) buyback spend in 2024 was $1.71B.

What was AbbVie buyback spend in 2025?

AbbVie (ABBV) buyback spend in 2025 was $980.00M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.